EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access

Risk Factors Associated With Post−COVID-19 Condition

Vasiliki Tsampasian, Hussein Elghazaly, Rahul Chattopadhyay, Maciej Debski, Thin Kyi Phyu Naing, Pankaj Garg, Allan Clark, Eleana Ntatsaki, Vassilios S Vassiliou

JAMA Internal Medicine · 01.06.2023 · 183 (6) · 566

DOI: 10.1001/jamainternmed.2023.0750 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift JAMA Internal Medicine, erschienen am 01.06.2023. Verfasst von Vasiliki Tsampasian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, UK. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 842-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Post−COVID-19 condition (PCC) is a complex heterogeneous disorder that has affected the lives of millions of people globally. Identification of potential risk factors to better understand who is at risk of developing PCC is important because it would allow for early and appropriate clinical support.

Objective

To evaluate the demographic characteristics and comorbidities that have been found to be associated with an increased risk of developing PCC. Data sources Medline and Embase databases were systematically searched from inception to December 5, 2022. Study Selection The meta-analysis included all published studies that investigated the risk factors and/or predictors of PCC in adult (≥18 years) patients. Data Extraction and Synthesis Odds ratios (ORs) for each risk factor were pooled from the selected studies. For each potential risk factor, the random-effects model was used to compare the risk of developing PCC between individuals with and without the risk factor. Data analyses were performed from December 5, 2022, to February 10, 2023. Main Outcomes and Measures The risk factors for PCC included patient age; sex; body mass index, calculated as weight in kilograms divided by height in meters squared; smoking status; comorbidities, including anxiety and/or depression, asthma, chronic kidney disease, chronic obstructive pulmonary disease, diabetes, immunosuppression, and ischemic heart disease; previous hospitalization or ICU (intensive care unit) admission with COVID-19; and previous vaccination against COVID-19.

Results

The initial search yielded 5334 records of which 255 articles underwent full-text evaluation, which identified 41 articles and a total of 860 783 patients that were included. The findings of the meta-analysis showed that female sex (OR, 1.56; 95% CI, 1.41-1.73), age (OR, 1.21; 95% CI, 1.11-1.33), high BMI (OR, 1.15; 95% CI, 1.08-1.23), and smoking (OR, 1.10; 95% CI, 1.07-1.13) were associated with an increased risk of developing PCC. In addition, the presence of comorbidities and previous hospitalization or ICU admission were found to be associated with high risk of PCC (OR, 2.48; 95% CI, 1.97-3.13 and OR, 2.37; 95% CI, 2.18-2.56, respectively). Patients who had been vaccinated against COVID-19 with 2 doses had a significantly lower risk of developing PCC compared with patients who were not vaccinated (OR, 0.57; 95% CI, 0.43-0.76). Conclusions and Relevance This systematic review and meta-analysis demonstrated that certain demographic characteristics (eg, age and sex), comorbidities, and severe COVID-19 were associated with an increased risk of PCC, whereas vaccination had a protective role against developing PCC sequelae. These findings may enable a better understanding of who may develop PCC and provide additional evidence for the benefits of vaccination. Trial Registration PROSPERO Identifier: CRD42022381002

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AdultHumansFemaleRisk FactorsComorbidityHospitalization

Autor:innen und Institutionen

  • Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, UK.
  • Norwich Medical School, University of East Anglia, Norwich, UK.
  • Imperial College London and Imperial College National Health Service Trust, London, UK.
  • Department of Cardiology, Cambridge University Hospitals, Cambridge, UK.
  • Department of Rheumatology, Ipswich Hospital, East Suffolk and North Essex National Health Service Foundation Trust, Ipswich, UK.
  • Department of Medicine, University College London, London, UK.

Zitieren

APA

Tsampasian, V., Elghazaly, H., Chattopadhyay, R., Debski, M., Naing, T. K. P., Garg, P., Clark, A., Ntatsaki, E., & Vassiliou, V. S. (2023). Risk Factors Associated With Post−COVID-19 Condition. JAMA Internal Medicine, 183(6), 566. https://doi.org/10.1001/jamainternmed.2023.0750

Vancouver

Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk Factors Associated With Post−COVID-19 Condition. JAMA Internal Medicine. 2023;183(6):566. doi:10.1001/jamainternmed.2023.0750

BibTeX
@article{Tsampasian2023,
  author = {Tsampasian, Vasiliki and Elghazaly, Hussein and Chattopadhyay, Rahul and Debski, Maciej and Naing, Thin Kyi Phyu and Garg, Pankaj and Clark, Allan and Ntatsaki, Eleana and Vassiliou, Vassilios S},
  title = {Risk Factors Associated With Post−COVID-19 Condition},
  journal = {JAMA Internal Medicine},
  year = {2023},
  volume = {183},
  number = {6},
  pages = {566},
  doi = {10.1001/jamainternmed.2023.0750}
}
Kostenlos starten →